Importantly, this increase appears to be statistically significant but physiologically benign, reflecting sustained creatine turnover rather than impaired kidney function
Standalone efficacy at clinically meaningful scale has not been demonstrated
Liu et al., 2014), a novel dimeric form of the K1 domain, designated K1K1 (Vallarola et al., 2020), the semi-synthetic engineered K1 domain, designed to be multimer by biotin-avidin interaction (Simonneau et al., 2015), a MET-agonistic DNA aptamer (Ueki et al., 2016, 2020), and MET-agonistic synthetic macrocyclic peptides (Sato et al., 2020)
This approach is carefully tailored to each individuals unique health profile to address challenges such as fatigue, cognitive difficulties, and age-related concerns that can inhibit vitality